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The Problem


Children and adolescents with abnormal lipid levels are at significant risk for
becoming adults with dyslipidemia with an increased risk for early
cardiovascular disease (CVD)



Early identification and control of dyslipidemia through child- and adulthood
can substantially reduce clinical CVD risk. Preliminary evidence of children
with heterozygous familial hypocholesteremia shows reduced subclinical
evidence of atherosclerosis with earlier treatment (Grade B)



Evidence has demonstrated that using family history as a primary factor to
identify children for screening would miss 30-60% of children with inherited
dyslipidemias (including 50% of those with familial hypocholesteremia)



Current medical organizations have incongruent guidelines and
recommendations for pediatric lipid screening that are based on expert
opinion only:





Bright Futures/American Academy of Pediatrics recommends universal
screening for children ages 9-11 and again at 17-21



USPSTF concludes the evidence is insufficient to recommend for or
against routine screening for lipid disorders in infants, children,
adolescents, or young adults up to age 20. (Grade I)

Current recommended screening strategies have low adherence rates by
pediatric health care providers. One study showed only 27.2% overall rate of
lipid screening at ages 9-11 (56% for high-risk children)

Cost Considerations


In the U.S today, 1 in 4 deaths are caused by heart disease and 1 in 20
deaths are caused by stroke



Heart disease and stroke account for more than $312.6 billion in direct
health care expenditures and lost productivity, and a projected $444 billion
in future costs.



A Fasting Lipid Panel (FLP) at UVMMC is $28.67 for the venipuncture and
$78.63 for the panel, totaling $107.30 per screening of out of pocket costs
(if no insurance coverage)



No report is available for total # of pediatric patients by age cohort at
Milton Family Practice, but roughly 10-12% of Family Medicine patients are
under the age of 18 and MFP has roughly 2000 patients.





Thus, an estimated 200-240 patients are under the age of 18 at MFP



Total estimated cost for two screenings per patient = $42,920 - $51,504
for venipuncture and results alone

There is considerable potential for psychological stress for venipuncture
alone in patients and their families. Additional psychological stressors exist
in patients/families not knowing the indication for the test, how to
interpret the test, or how to cope with the potential treatment and
management of the results.

Community Perspective
COLLECTED VIA


Contacting experts in the following departments: Family Medicine, Pediatrics,
Pediatric Cardiology, Pediatric Gastroenterology



Interviewing Dr. Kimberly Hageman (MFP, VCHIP Fit & Healthy Vermonters
Toolkit Development Team, Pilot Tester)



Interviewing Dr. Anne Morris (MFP)



Interviewing Holly Van Winkle (Practice Supervisor, MFP)



Communicating with PRISM information services in regards to SmartPhrases,
Reporting, and Flowsheet capabilities



Creating 6-question survey distributed to MFP providers to gain perspective

FINDINGS


Only 25% (2) providers at MFP “Agreed” that they were comfortable applying
the pediatric lipid screening guidelines



75% (6) chose the 9-11yo and only 50.0% (4) chose ages 17-21 for the correct
age groups to be universally screened. 37.51% (3) chose the incorrect age
group of age 12-16yo



Family Medicine providers feel there is limited evidence for the
treatment/management for hyperlipidemia in children



For practical reasons (lack of evidence, unclear and conflicting guidelines, lack
of time to educate patients and families, difficulty obtaining venopuncture in
children), providers report “going against the guidelines”



Reporting and flowsheets using EHR have limited flexibility and functionality to
run specific inquiries. Building these functionalities takes weeks-months and
costs considerable health care dollars

Community Perspective, cont.
SURVEY RESULTS (n=8)

FREE TEXT COMMENTS











“I do not think it makes sense. I am not going to
prescribe a statin drug to an adolescent. We should
be able to have frank discussions about obesity, diet,
and exercise, without lab work.”
“It would be nice to tie it to services that assist
children and families to make effective lifestyle
changes.”
“Education is needed on this topic.”
“…would love more information to help guide my
practice.”
“no clear evidence to support this, only expert panel
recs, small number of kids in practice and so very
small % kids who would have true significant
dyslipidemias requiring more aggressive management
than routine rec diet and exercise”
“I don't know the screening guidelines”
“Have not seen a large number of patients who
qualify, will likely screen more in the future.”

Methodology


Researched and categorized information on pediatric lipid
screening guidelines



Created survey using SurveyMonkey to collect information
on Milton Family Practice (MFP) provider’s knowledge and
perspectives of the guidelines



Ran PRISM report exploring # of patients 9-11yo without
lipid results at MFP (No report available for 17-21yo)



Developed SmartPhrase in Epic to help providers know 1)
who to screen 2)when to screen and 3)how to manage
results



Circulated survey results, report results, and
SmartPhrases to providers and staff at MFP

Recommended Pediatric
Lipid and Lipoprotein Cutpoints
Goal

Borderline

High+
(Low for HDL)

Total Cholesterol

<170 (0-19yrs)
<190 (20-24yrs)

170-199 (0-19yrs)
190-224 (20-24yrs)

≥200 (0-19yrs)
≥225 (20-24yrs)

LDL-C

<110 (0-19yrs)
<120 (20-24yrs)

110-129 (0-19yrs)
120-159 (20-24yrs)

≥130 (0-19yrs)
≥160 (0-24yrs)

Non-HDL-C

<120 (0-19yrs)
<150 (20-24yrs)

120-144 (0-19yrs)
150-189 (0-24yrs)

≥145 (0-19yrs)
≥190 (20-24yrs)

HDL-C

>45 (0-19yrs)
>45 (20-24yrs)

40-45 (0-19yrs)
40-44 (20-24yrs)

<40 (0-19yrs)
<40 (20-24yrs)

Trigs

<75 (0-9yrs)
<90 (10-19yrs)
<115 (20-24yrs)

75-99 (0-9yr)
90-129 (10-19yrs)
115-149 (20-24yrs)

≥100 (0-9yr)
≥130 (10-19yr)
≥150 (20-24yrs)



Bright Futures/American Academy of Pediatrics
recommends universal screening for children ages 9-11 and
again at 17-21



USPSTF concludes the evidence is insufficient to recommend
for or against routine screening for lipid disorders in infants,
children, adolescents, or young adults up to age 20 (Grade I)

Results
SURVEY


See survey results under “Community Perspective”

PRISM REPORT




Currently at MFP, there are 111 patients ages 9-11 who
have NOT been screened for lipids per the guidelines:
[9yo (n=25); 10yo (n=47); 11yo (n=39)]
At MFP 36.23% of children are overweight/obese
(no age specific data available)




ALL Family Medicine Departments in the UVMMC
Network


2-5yo = 463 (19%)



6-11yo = 667 (28%)



12-17yo = 969 (40%)



18-21yo=316 (13%)

No report available for patients ages 17-21

SMARTTEXT


SmartText with Flowsheet for the Universal Screening
Guidelines for Ages 9-11 and for 17-21 currently
available in PRISM as [pedslipidgoals] (next slide)

VCHIP Reporting Data

Results, cont.
SMARTTEXT


Developed from Bright Futures/AAP guidelines for universal pediatric
lipid screening as a quick way for providers to assess results and
communicate the appropriate management next steps.

Evaluation
EFFECTIVENESS


Based on survey results, there is ambiguity in knowing the guidelines and
the application of the guidelines in clinical practice



Evaluation could be done in conjunction with the VCHIP Obesity Work with
Pediatricians, and/or by specific family practices to monitor the
implementation of the guidelines and the use of the SmartPhrase



From the survey, 37.5% Strongly Agreed and 62.5% Agreed that “A PRISM
screening tool for who/when to screen pediatric patients and for how to
interpret results would help provide quality health care”

Questions should address what other practices, specifically in pediatrics,
are doing in regards to Pediatric Lipid Screening, what resources are
currently available, and how providers implement and communicate the
guidelines with patients and their families
LIMITATIONS




Universal pediatric lipid screening is based on expert opinion, not on
randomized control trials or observational a studies exploring the benefits
and utility of the practice



Family Medicine Practices generally follow USPSTF guidelines, not Bright
Futures/AAP guidelines, and for pediatric lipid screening, there are differing
guidelines



Inability to interview experts in pediatric cardiology and gastroenterology,
who manage and consult for pediatric lipids. Input on what is currently
being done in pediatric clinics could help guide practice in Family Medicine



Inability to develop reporting and flowsheets in PRISM without consultation
and financing support through information services



Implementation ultimately up to providers, unless mandated by practice

Recommendations
EDUCATION


Distribute survey to all UVMMC Family Practice providers



Create a curriculum for Family Medicine provider’s on the guidelines and
recommendations for Universal Pediatric Lipid Screening including reports and
SmartText, building off presentation by Dr. Hageman’s pediatric
obesity/VCHIP work



Implement and distribute biannual reports on universal pediatric lipid
screening by provider to monitor adherence

REPORTING


Create Report for “Lipid Screening – PC – Patients 17-21 Never Had (My Dept)”
in PRISM to identify patients to be screened



Consider including lipid screening to Health Maintenance tab for all 9-11yo
and 17-21yo within the FM Department



Consider including lipid screening as part of the VCHIP Population based
reports that are working to get children in every 24 months for a Well Child
Check up.

IMPLEMENTATOIN


Consider including lipids as a Point-of-Care Testing (POCT) to increase
likelihood that the patient and provider will receive results and have the
opportunity to discuss the results and if applicable, act on immediate clinical
management decisions



Consider converting SmartPhrase to SmartSet or Pathway/Flowsheet to
improve provider adherence to the guidelines



Monitor how often/who is using the SmartPhrase in PRISM
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